Fosdagrocorat (developmental code names PF-04171327 and PF-4171327; also known as dagrocorat 2-(dihydrogen phosphate)) is a nonsteroidal but steroid-like selective glucocorticoid receptor modulator (SGRM) which was under development for the treatment of rheumatoid arthritis but was never marketed. It is the C2 dihydrogen phosphate ester of dagrocorat, and acts as a prodrug of dagrocorat with improved pharmacokinetics. The drug reached phase II clinical trials prior to the discontinuation of its development. See also AZD-5423 Mapracorat Dagrocorat References External links Fosdagrocorat - AdisInsight Anti-inflammatory agents Carboxamides Glucocorticoids Phenanthrenes Phenyl compounds Phosphate esters Prodrugs Pyridines Selective glucocorticoid receptor modulators Trifluoromethyl compounds